CMR316 / Scripps Research Institute - LARVOL DELTA

Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis (clinicaltrials.gov) - P1 | N=89 | Completed | Sponsor: Calibr, a division of Scripps Research | Recruiting ➔ Completed | Trial completion date: Mar 2026 ➔ Jun 2026 | Trial primary completion date: Mar 2026 ➔ Jun 2026

Trial completion • Trial completion date • Trial primary completion date • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases